Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05511337Not ApplicableUnknown

Gut Microbiota in Patients With Urolithiasis

Role: lead

NCT04110392Not ApplicableCompleted

Effect of Consumption of Chaya on Lipid Concentration and Antioxidant Status of Patients With Dyslipidemia

Role: lead

NCT05307159Not ApplicableCompleted

Effect of a Bean Protein-added Supplement on Body Composition in High-performance Adolescent Athletes

Role: lead

NCT04165356Not ApplicableUnknown

Efficacy of Mouth-rinse With Chlorhexidine for the Prevention of Ventilator-associated Infections in Intensive Care Unit

Role: collaborator

All 4 trials loaded